Eric Liebler Email & Phone Number

Mr. Liebler has more than 20 years of neurological industry and association experience. In 2009, he co-founded Nautilus Neurosciences, a neurology-focused specialty pharmaceutical company focused on identifying and developing drugs benefitting those affected by neurological disorders, to market Cambia® for the treatment of acute migraine. At Nautilus, Mr. Liebler was involved in all facets of the company’s organization and early success including initial funding, product commercialization and sales and marketing. Mr. Liebler has held leadership positions at Elan, Amarin, Enzon Pharmaceuticals, Questcor Pharmaceuticals, and Pharmacopeia. He founded Nisola LLC, an advocacy and business strategy-consulting firm focused on serving clients in the field of neurology, and sat on the Board of Trustees of the American Academy of Neurology Foundation (now the American Brain Foundation) for more than a decade. Mr. Liebler began his career at Athena Neurosciences, a pioneer in the development of neurology drugs. Specialties: Management, Marketing, Business Development, Strategic Planning, M&A, Equity raising, pharmaceutical sales, KOL development.

Listed skills include Neurology, Pharmaceutical Industry, Biotechnology, Pharmaceutical Sales, and 17 others.

• 

  Tufts University

  International Relations